Versiti Blood Research Institute
@versitiresearch.bsky.social
The VBRI is dedicated to hematology in all its facets, spanning basic, translational and clinical research, all with one goal: to make people’s lives better.
https://versiti.org/versiti-blood-research-institute
https://versiti.org/versiti-blood-research-institute
Quick peek at the 2nd deck concrete pour of the VBRI expansion! From groundbreaking 11 months ago to this milestone! We're building the future of blood health research day by day. #PublicHealth #BloodHealth
August 6, 2025 at 2:45 PM
Quick peek at the 2nd deck concrete pour of the VBRI expansion! From groundbreaking 11 months ago to this milestone! We're building the future of blood health research day by day. #PublicHealth #BloodHealth
The Kastrup Lab @ VBRI recently published a technique that may prevent dangerous blood clots after trauma without stopping normal healing. The targeted siRNA therapy keeps clotting proteins in the safe zone in the murine model. Learn more: journals.lww.com/jtrauma/abst...
August 4, 2025 at 2:36 PM
The Kastrup Lab @ VBRI recently published a technique that may prevent dangerous blood clots after trauma without stopping normal healing. The targeted siRNA therapy keeps clotting proteins in the safe zone in the murine model. Learn more: journals.lww.com/jtrauma/abst...
We're proud to stand with our colleagues at @ash.hematology.org and the #Fight4Hematology campaign. Supporting emerging researchers and innovative care approaches strengthens our entire field's capacity to transform lives. Learn more and get involved: www.hematology.org/advocacy/fig...
Fight4Hematology - Hematology.org
Fight4Hematology
www.hematology.org
July 22, 2025 at 6:47 PM
We're proud to stand with our colleagues at @ash.hematology.org and the #Fight4Hematology campaign. Supporting emerging researchers and innovative care approaches strengthens our entire field's capacity to transform lives. Learn more and get involved: www.hematology.org/advocacy/fig...
Reposted by Versiti Blood Research Institute
Congratulations to Bob Montgomery @versitiresearch.bsky.social for the being the recipient of the 2025 Harold R. Roberts Award @isth.org #ISTH2025
June 21, 2025 at 9:40 PM
Congratulations to Bob Montgomery @versitiresearch.bsky.social for the being the recipient of the 2025 Harold R. Roberts Award @isth.org #ISTH2025
Reposted by Versiti Blood Research Institute
🥳The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery in recognition of his enduring contributions. His decades of leadership through the ISTH SSC and @versitiresearch.bsky.social reflect a career shaped by curiosity, perseverance & impact.
Read more: bit.ly/3FO1cVe
Read more: bit.ly/3FO1cVe
June 13, 2025 at 5:09 PM
🥳The ISTH proudly presents the Harold R. Roberts Award to Dr. Robert R. Montgomery in recognition of his enduring contributions. His decades of leadership through the ISTH SSC and @versitiresearch.bsky.social reflect a career shaped by curiosity, perseverance & impact.
Read more: bit.ly/3FO1cVe
Read more: bit.ly/3FO1cVe
PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia
pubmed.ncbi.nlm.nih.gov/40191970/
pubmed.ncbi.nlm.nih.gov/40191970/
PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia - PubMed
These findings suggest that the PEA is a promising functional test for HIT laboratory diagnostics based on the relatively high sensitivity; however, further studies are needed to validate its clinical...
pubmed.ncbi.nlm.nih.gov
April 28, 2025 at 6:56 PM
PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia
pubmed.ncbi.nlm.nih.gov/40191970/
pubmed.ncbi.nlm.nih.gov/40191970/
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression: pubmed.ncbi.nlm.nih.gov/40196236/
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression - PubMed
The use of sNK cells in immunotherapy emerges as a potentially effective strategy to target and eliminate the majority of ovarian tumour clones, thereby providing a potential therapeutic opportunity i...
pubmed.ncbi.nlm.nih.gov
April 28, 2025 at 6:53 PM
Supercharged NK cells, unlike primary activated NK cells, effectively target ovarian cancer cells irrespective of MHC-class I expression: pubmed.ncbi.nlm.nih.gov/40196236/
Great work and great collaboration! #TeamScience
Learn more about Dr. Alan Mast and the Thrombosis and Hemostasis Lab at Versiti: versiti.org/versiti-bloo...
Learn more about Dr. Alan Mast and the Thrombosis and Hemostasis Lab at Versiti: versiti.org/versiti-bloo...
April 24, 2025 at 6:22 PM
Great work and great collaboration! #TeamScience
Learn more about Dr. Alan Mast and the Thrombosis and Hemostasis Lab at Versiti: versiti.org/versiti-bloo...
Learn more about Dr. Alan Mast and the Thrombosis and Hemostasis Lab at Versiti: versiti.org/versiti-bloo...
Join us on Wed. 4/23 as we showcase the groundbreaking work of women in science at the VBRI!
All ages are welcome as we profile the impactful innovation coming from @versiti.bsky.social and inspire future researchers.
Register for free: versiti.org/ways-to-give...
#WeResearchCures
All ages are welcome as we profile the impactful innovation coming from @versiti.bsky.social and inspire future researchers.
Register for free: versiti.org/ways-to-give...
#WeResearchCures
April 8, 2025 at 7:42 PM
Join us on Wed. 4/23 as we showcase the groundbreaking work of women in science at the VBRI!
All ages are welcome as we profile the impactful innovation coming from @versiti.bsky.social and inspire future researchers.
Register for free: versiti.org/ways-to-give...
#WeResearchCures
All ages are welcome as we profile the impactful innovation coming from @versiti.bsky.social and inspire future researchers.
Register for free: versiti.org/ways-to-give...
#WeResearchCures
At Versiti Perspective: Sickle Cell Disease, experts, advocates and community members joined to advance awareness and research. Guests heard from Chris Miskel, Prithu Sundd, Ph.D., and more, toured VBRI and learned their blood type. Give blood, save lives: bitly.versiti.org/3DaSHlw.
March 4, 2025 at 2:52 PM
At Versiti Perspective: Sickle Cell Disease, experts, advocates and community members joined to advance awareness and research. Guests heard from Chris Miskel, Prithu Sundd, Ph.D., and more, toured VBRI and learned their blood type. Give blood, save lives: bitly.versiti.org/3DaSHlw.
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators
pubmed.ncbi.nlm.nih.gov/39643951/
pubmed.ncbi.nlm.nih.gov/39643951/
Elevated frequencies of activated memory B cells in multiple sclerosis are reset to healthy control levels after B cell depletion with Ocrelizumab - PubMed
In multiple sclerosis (MS) the B cell depleting drug ocrelizumab has shown high efficacy in reducing inflammatory activity. Its mechanism of action is unclear due to B cell subset complexity and unkno...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:56 PM
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators
pubmed.ncbi.nlm.nih.gov/39643951/
pubmed.ncbi.nlm.nih.gov/39643951/
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators
pubmed.ncbi.nlm.nih.gov/39652409/
pubmed.ncbi.nlm.nih.gov/39652409/
The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative - PubMed
Clinical trial design for classical hematologic diseases is difficult because samples sizes are often small and not representative of the disease population. The American Society of Hematology initiat...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:50 PM
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators
pubmed.ncbi.nlm.nih.gov/39652409/
pubmed.ncbi.nlm.nih.gov/39652409/
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann Kreuziger and collaborators
pubmed.ncbi.nlm.nih.gov/39930618/
pubmed.ncbi.nlm.nih.gov/39930618/
Lack of Standardized Coding Limits Accuracy of Electronic Clinical Quality Measure for Pulmonary Embolism Diagnosis - PubMed
Guidelines for diagnosing pulmonary embolism (PE) start with a risk assessment using a pretest probability (PTP) tool, followed by D-dimer testing or computed tomography pulmonary angiography (CTPA) d...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:46 PM
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann Kreuziger and collaborators
pubmed.ncbi.nlm.nih.gov/39930618/
pubmed.ncbi.nlm.nih.gov/39930618/
Check out publication by VBRI Associate investigator Dipa Pradhan-Sundd and collaborators
pubmed.ncbi.nlm.nih.gov/39936985/
pubmed.ncbi.nlm.nih.gov/39936985/
Heme-Oxygenase 1 Mediated Activation of Cyp3A11 Protects Against Non-Steroidal Pain Analgesics Induced Acute Liver Damage in Sickle Cell Disease Mice - PubMed
Pain constitutes a significant comorbidity associated with sickle cell disease (SCD). Analgesics serve as the primary method for pain management; however, the long-term effects of these drugs on the l...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:41 PM
Check out publication by VBRI Associate investigator Dipa Pradhan-Sundd and collaborators
pubmed.ncbi.nlm.nih.gov/39936985/
pubmed.ncbi.nlm.nih.gov/39936985/
Check out publication by VBRI Associate investigator Yiliang Chen and collaborators
pubmed.ncbi.nlm.nih.gov/39943809/
pubmed.ncbi.nlm.nih.gov/39943809/
Angiotensin 1-7 and a TERT activator individually restore vasodilatory capacity within the microcirculation previous SARS-CoV-2 infection - PubMed
Angiotensin 1-7 and a TERT activator individually restore vasodilatory capacity within the microcirculation previous SARS-CoV-2 infection
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:38 PM
Check out publication by VBRI Associate investigator Yiliang Chen and collaborators
pubmed.ncbi.nlm.nih.gov/39943809/
pubmed.ncbi.nlm.nih.gov/39943809/
Check out publication by VBRI Associate investigator Joshua Muia and collaborators
pubmed.ncbi.nlm.nih.gov/39945068/
pubmed.ncbi.nlm.nih.gov/39945068/
Arginine Methylation by PRMT1 Affects ADAMTS13 Secretion and Enzymatic Activity - PubMed
These results demonstrate the crucial role of arginine methylation on ADAMTS13 secretion and activity. Our findings may shed new light on the mechanism of allosteric regulation of ADAMTS13, which may ...
pubmed.ncbi.nlm.nih.gov
February 14, 2025 at 4:35 PM
Check out publication by VBRI Associate investigator Joshua Muia and collaborators
pubmed.ncbi.nlm.nih.gov/39945068/
pubmed.ncbi.nlm.nih.gov/39945068/
Check out publication by VBRI Senior Investigator Emeritus Thomas Abshire and collaborators
pubmed.ncbi.nlm.nih.gov/39461724/
pubmed.ncbi.nlm.nih.gov/39461724/
Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years - PubMed
These findings support durability of the Kids-DOTT randomized clinical trial findings of net clinical benefit at 2 years.
pubmed.ncbi.nlm.nih.gov
February 7, 2025 at 4:49 PM
Check out publication by VBRI Senior Investigator Emeritus Thomas Abshire and collaborators
pubmed.ncbi.nlm.nih.gov/39461724/
pubmed.ncbi.nlm.nih.gov/39461724/
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators
pubmed.ncbi.nlm.nih.gov/39536817/
pubmed.ncbi.nlm.nih.gov/39536817/
Examining downstream effects of concizumab in hemophilia A with a mathematical modeling approach - PubMed
The effectiveness of concizumab is mediated through the blockade of TFPI anticoagulant activities in plasma and on multiple physiological surfaces. An important and previously unrecognized function of...
pubmed.ncbi.nlm.nih.gov
February 7, 2025 at 4:43 PM
Check out publication by VBRI Senior Investigator and Program Co-Leader Alan Mast and collaborators
pubmed.ncbi.nlm.nih.gov/39536817/
pubmed.ncbi.nlm.nih.gov/39536817/
Check out publication by VBRI Senior investigator Jieqing Zhu and collaborators in
pubmed.ncbi.nlm.nih.gov/39906208/
pubmed.ncbi.nlm.nih.gov/39906208/
Borrelia burgdorferi tolerates alteration to P66 porin function in a murine infectivity model - PubMed
<span><i>Borrelia burgdorferi</i> exists in a complex enzootic life cycle requiring differential gene regulation. P66, a porin and adhesin, is upregulated and essential during mammalian infection, but...
pubmed.ncbi.nlm.nih.gov
February 7, 2025 at 4:38 PM
Check out publication by VBRI Senior investigator Jieqing Zhu and collaborators in
pubmed.ncbi.nlm.nih.gov/39906208/
pubmed.ncbi.nlm.nih.gov/39906208/
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann-Kreuziger and collaborators in pubmed.ncbi.nlm.nih.seniorgov/39911106/
Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation - PubMed
Not available.
pubmed.ncbi.nlm.nih.gov
February 7, 2025 at 4:35 PM
Check out publication by VBRI Senior Medical Director, Investigator Lisa Baumann-Kreuziger and collaborators in pubmed.ncbi.nlm.nih.seniorgov/39911106/
Angela Beltrame spoke with students about her work, her journey and how she came to collaborate with the VBRI.
January 31, 2025 at 3:19 PM
Angela Beltrame spoke with students about her work, her journey and how she came to collaborate with the VBRI.
Dr. Alexis Smith spoke with students about her interest in science and her journey.
January 31, 2025 at 3:15 PM
Dr. Alexis Smith spoke with students about her interest in science and her journey.
Communications Committee Presents: High School Students
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. Jayson Bartlein came to speak with the students about his role at the VBRI.
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. Jayson Bartlein came to speak with the students about his role at the VBRI.
January 31, 2025 at 3:12 PM
Communications Committee Presents: High School Students
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. Jayson Bartlein came to speak with the students about his role at the VBRI.
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. Jayson Bartlein came to speak with the students about his role at the VBRI.
Communications Committee Presents: High School Students
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. We had Dawn Wenzel come share information regarding programs at MCW.
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. We had Dawn Wenzel come share information regarding programs at MCW.
January 31, 2025 at 3:07 PM
Communications Committee Presents: High School Students
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. We had Dawn Wenzel come share information regarding programs at MCW.
Bradley Tech high school students visit the VBRI on 1/29/2025 to learn more about science/research opportunities at the Versiti Blood Research Institute. We had Dawn Wenzel come share information regarding programs at MCW.
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators in pubmed.ncbi.nlm.nih.gov/39879070/
What's on the horizon? - PubMed
What's on the horizon?
pubmed.ncbi.nlm.nih.gov
January 31, 2025 at 2:46 PM
Check out publication by VBRI Senior investigator Bonnie Dittel and collaborators in pubmed.ncbi.nlm.nih.gov/39879070/